Literature DB >> 24742474

American Society of Nephrology Quiz and Questionnaire 2013: transplantation.

Michelle A Josephson1, Mark A Perazella2, Michael J Choi3.   

Abstract

The nephrology quiz and questionnaire remains an extremely popular session for attendees of the Annual Meeting of the American Society of Nephrology. As in past years, the conference hall was overflowing with interested audience members. Topics covered by expert discussants included electrolyte and acid-base disorders, glomerular disease, ESRD/dialysis, and transplantation. Complex cases representing each of these categories along with single best answer questions were prepared by a panel of experts. Before the meeting, program directors of United States nephrology training programs answered questions through an Internet-based questionnaire. A new addition to the nephrology quiz and questionnaire was participation in the questionnaire by nephrology fellows. To review the process, members of the audience test their knowledge and judgment on a series of case-oriented questions prepared and discussed by experts. Their answers are compared in real time using audience response devices with the answers of nephrology fellows and training program directors. The correct and incorrect answers are then briefly discussed after the audience responds, and the results of the questionnaire are displayed. This article recapitulates the session and reproduces its educational value for the readers of CJASN. Enjoy the clinical cases and expert discussions.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Keywords:  drug interactions; immunosuppression; rejection; renal transplantation

Mesh:

Year:  2014        PMID: 24742474      PMCID: PMC4078971          DOI: 10.2215/CJN.12641213

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  32 in total

1.  Sirolimus may promote thrombotic microangiopathy.

Authors:  Jocelyne A Saikali; Luan D Truong; Wadi N Suki
Journal:  Am J Transplant       Date:  2003-02       Impact factor: 8.086

2.  Effects of rifampin on cyclosporine disposition in kidney recipients with tuberculosis.

Authors:  Y H Kim; Y R Yoon; Y W Kim; J G Shin; I J Cha
Journal:  Transplant Proc       Date:  1998-11       Impact factor: 1.066

3.  Antituberculous drugs in kidney transplant recipients treated with cyclosporine.

Authors:  B Peschke; W Ernst; J Gossmann; H G Kachel; W Schoeppe; E H Scheuermann
Journal:  Transplantation       Date:  1993-07       Impact factor: 4.939

4.  Treatment of hemolytic anemia and severe thrombocytopenia with high-dose methylprednisolone and intravenous immunoglobulins in SLE.

Authors:  R Roldan; J Roman; D Lopez; J Gonzalez; C Sanchez; F Martinez
Journal:  Scand J Rheumatol       Date:  1994       Impact factor: 3.641

5.  Clinical features and outcomes of tuberculosis in solid organ transplant recipients.

Authors:  M Bodro; N Sabé; M Santín; J M Cruzado; L Lladó; J González-Costello; J Carratalà
Journal:  Transplant Proc       Date:  2012-11       Impact factor: 1.066

Review 6.  Post-transplant lymphoproliferative disorder.

Authors:  N Basgoz; J K Preiksaitis
Journal:  Infect Dis Clin North Am       Date:  1995-12       Impact factor: 5.982

7.  Isoniazid does not affect bioavailability of cyclosporine in renal transplant recipients.

Authors:  K Sud; T Muthukumar; B Singh; S K Garg; H S Kohli; V Jha; K L Gupta; V Sakhuja
Journal:  Methods Find Exp Clin Pharmacol       Date:  2000-10

8.  Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations.

Authors:  A T Pavia; C R Nichols; D P Green; R V Tauxe; S Mottice; K D Greene; J G Wells; R L Siegler; E D Brewer; D Hannon
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

9.  Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers.

Authors:  M F Hebert; R M Fisher; C L Marsh; D Dressler; I Bekersky
Journal:  J Clin Pharmacol       Date:  1999-01       Impact factor: 3.126

10.  Tuberculosis in South-East Asian refugees after resettlement--can prevention be improved by better policy and practice?

Authors:  C R MacIntyre; A J Plant
Journal:  Prev Med       Date:  1998 Nov-Dec       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.